Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Preventive Healthcare Technologies and Services Market Share

Report ID: GMI7106
   |
Published Date: October 2023
 | 
Report Format: PDF

Download free sample

Preventive Healthcare Technologies and Services Market Share

The preventive healthcare technologies and services industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Teladoc Health, holds a significant share in the market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Teladoc Health, introduced the Chronic Care Complete, a first-of-its-kind chronic condition management solution to help individuals recover their health outcomes.
 

Some of the eminent market participants operating in the preventive healthcare technologies and services industry include:

  • GlaxoSmithKline
  • Omnicell, Inc
  • Myriad Genetics
  • Omron Healthcare
  • Abbott Laboratories
  • Medtronic
  • Quest Diagnostics
  • Merck & Co. Inc.
  • Sanofi
  • NOVX Systems Corp
  • Moderna, Inc
  • Pfizer
  • Teladoc Health         
  • McKesson Corporation
  • Practice Fusion Inc.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
How is the demand for preventive healthcare technologies and services driven in hospitals?
The hospitals end-use segment held over 41% of the preventive healthcare technologies and services industry share in 2022 propelled by the strong presence of skilled healthcare professionals.
How big is the preventive healthcare technologies and services market?
What is the value of the U.S. preventive healthcare technologies and services market?
Who are the major preventive healthcare technologies and services industry players?
Preventive Healthcare Technologies and Services Market Scope

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & workings

1.3    Forecast calculations

1.4    Data Sources

1.4.1    Primary

1.4.2    Secondary

1.4.2.1   Paid sources

1.4.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Global preventive healthcare technologies and services market 360Β° synopsis, 2018 – 2032

2.2    Regional trends

2.3    Type trends

2.4    End-use trends

Chapter 3   Preventive Healthcare Technologies and Services Industry Insights

3.1    COVID- 19 impact analysis

3.2    Industry ecosystem analysis

3.3    Technology landscape

3.4    Regulatory landscape

3.5    Industry impact forces

3.5.1    Growth drivers

3.5.1.1   Growing burden of chronic diseases

3.5.1.2   Increasing adoption of digital healthcare technology

3.5.1.3   Growing number of awareness programs by the government.

3.5.1.4   Advancement in preventive healthcare technology

3.5.2    Industry pitfalls & challenges

3.5.2.1   Lack of healthcare IT professionals

3.5.2.2   Stringent regulatory scenario

3.6    Growth potential analysis

3.6.1    By type

3.6.2    By end-use

3.7    Porter's analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.1.1    GlaxoSmithKline

4.1.2    Abbott Laboratories

4.1.3    Merck & Co. Inc

4.2    Competitive analysis of major market players, 2022

4.3    Competitive positioning matrix, 2022

4.4    Strategic outlook matrix, 2022

Chapter 5   Preventive Healthcare Technologies and Services Market Size and Forecast, By Type, 2018-2032 (USD Million)

5.1    Key trends, by type

5.2    Early detection and screening

5.2.1    Automated screening

5.2.2    Personalized medicine

5.2.3    Other advanced screening technologies

5.3    Chronic disease management technologies

5.3.1    Blood pressure monitors

5.3.2    Asthma monitors

5.3.3    Cardiovascular monitors

5.3.4    Glucose monitors

5.4    Vaccines

5.4.1    Infectious diseases

5.4.2    Combined tetanus-diphtheria-pertussis vaccines

5.4.3    Allergy

5.4.4    Others

5.5    Advanced technologies to reduce errors

5.5.1    Electronic prescribing

5.5.2    Clinical decision support system

5.5.3    Smart infusion pumps

5.5.4    Computerized provider order entry system

5.5.5    Smart packaging

5.5.6    Automated prescription formulation & dispensing

Chapter 6   Preventive Healthcare Technologies and Services Market Size and Forecast, By End-use, 2018-2032 (USD Million)

6.1    Key trends, by end-use

6.2    Hospitals

6.3    Clinics

6.4    Other end-users

Chapter 7   Preventive Healthcare Technologies and Services Market Size and Forecast, By Region, 2018-2032 (USD Million)

7.1    Key trends, by region

7.2    North America

7.2.1    U.S.

7.2.2    Canada

7.3    Europe

7.3.1    Germany

7.3.2    UK

7.3.3    France

7.3.4    Italy

7.3.5    Spain

7.3.6    Rest of Europe

7.4    Asia Pacific

7.4.1    China

7.4.2    Japan

7.4.3    India

7.4.4    Australia

7.4.5    South Korea

7.4.6    Rest of Asia Pacific

7.5    Latin America

7.5.1    Brazil

7.5.2    Mexico

7.5.3    Argentina

7.5.4    Rest of Latin America

7.6    Middle East & Africa

7.6.1    South Africa

7.6.2    Saudi Arabia

7.6.3    UAE

7.6.4    Rest of Middle East & Africa

Chapter 8   Company Profiles

8.1    GlaxoSmithKline

8.2    Omnicell, Inc

8.3    Myriad Genetics

8.4    Omron Healthcare

8.5    Abbott Laboratories

8.6    Medtronic

8.7    Quest Diagnostics

8.8    Merck & Co. Inc.

8.9    Sanofi

8.10    NOVX Systems Corp

8.11    Moderna, Inc

8.12    Pfizer

8.13    Teladoc Health

8.14    McKesson Corporation

8.15    Practice Fusion Inc

   

Authors: Mariam Faizullabhoy, Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,280 $5,350
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2023

Companies covered: 15

Tables & Figures: 400

Countries covered: 18

Pages: 180

Download Free Sample

Top